Insider · CIK 0000886163
Ligand Pharmaceuticals Inc
Files at PTHS (Pelthos Therapeutics Inc.). First filing -, latest -.
In brief
Ligand Pharmaceuticals Inc files SEC Form 4 as 10% owner and director at PTHS (Pelthos Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ligand Pharmaceuticals Inc has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | PTHS Pelthos Therapeutics Inc. | DDisposition to issuer Senior Secured Convertible Notederivative | - | - | - | 0 | Dec 19, 2025 |
| Dec 17, 2025 | PTHS Pelthos Therapeutics Inc. | AGrant or award Senior Secured Convertible Notederivative | - | - | - | - | Dec 19, 2025 |
| Nov 6, 2025 | PTHS Pelthos Therapeutics Inc. | AGrant or award Senior Secured Convertible Notederivative | - | $9,000,000.00 | - | - | Nov 10, 2025 |
| Jul 1, 2025 | PTHS Pelthos Therapeutics Inc. | CConversion Common Stock | +1,500,000 | $10.00 | $15M | 1,500,000 | Jul 3, 2025 |
| Jul 1, 2025 | PTHS Pelthos Therapeutics Inc. | CConversion Series A Convertible Preferred Stockderivative | -15,000 | $0.00 | $0 | 3,000 | Jul 3, 2025 |
| Jul 1, 2025 | PTHS Pelthos Therapeutics Inc. | JOther Series A Convertible Preferred Stockderivative | +31,279 | - | - | 34,279 | Jul 3, 2025 |
Questions about Ligand Pharmaceuticals Inc
Answered from the filings on this page, as of the latest one.
Is Ligand Pharmaceuticals Inc buying or selling?
Ligand Pharmaceuticals Inc has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ligand Pharmaceuticals Inc's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ligand Pharmaceuticals Inc has 0.
Where does Ligand Pharmaceuticals Inc file Form 4?
Ligand Pharmaceuticals Inc has filed Form 4 at PTHS (Pelthos Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.